FDA scientific conference grant
The Association of Food and Drug Officials (AFDO) will apply for a scientific conference grant from the U.S. Food and Drug Administration. The purpose of the award is to provide scholarships to state and local food & drug regulatory personnel to attend the 2024 AFDO Annual Educational Conference (AEC).
All applications must be submitted no later than the close of business on Friday, March 15, 2024
The Scholarship Review Committee will consider each application. In some cases, we will only be able to assist with partial funding, but we will attempt to pay for a minimum of fifty percent of the cost of conference attendance to those selected recipients. Applicants should not make travel arrangements until they have received confirmation of selection.
Selected recipients will be notified by Friday, March 29, 2024
Criteria for receiving funding will be based upon several factors such as: whether or not your agency has funded participation in the past; the number of participants previously and currently funded by your agency; how active you have been in AFDO; and any other sources of funding available to you, including agency reimbursement and/or regional affiliate assistance. Preference will also be given to states which have active food, drug, and medical device regulatory programs and who have not been able to fund a representative due to the lack of out-of-state travel funds.
Contact Christina Heist at cheist@afdo.org with any questions or concerns.
Special Note
Grant funds are extremely limited and cannot be utilized for Food or Registration Fees. Please apply for funding only if you have no other option for attending the conference.
Please feel free to pass this announcement along to other members of your staff who you believe would benefit from attending the AFDO Annual Educational Conference.
This funding is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award FAIN #R13FD006980 totaling $50,000 with 100 percent funded by FDA/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.